Stockreport

Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Acasunlimab is an investigational bispecific antibody, which aims to elicit an antitumor response through conditional activation of 4-1BB on T cells and natural killer [Read more]